Skip to Main Content

Paper Details

Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults - United States, August-December 2021.
MMWR Morb Mortal Wkly Rep
67
2022
Adults, COVID, COVID-19, COVID-19 mRNA, SARS, SARS-CoV-2, immunocompromising conditions, mRNA, mRNA-1273, patients, persons
2019-nCoV Vaccine mRNA-1273, Adult, Aged, BNT162 Vaccine, COVID-19, Female, Hospitalization, Humans, Immunization, Secondary, Immunocompetence, Immunocompromised Host, Male, Middle Aged, SARS-CoV-2, United States, Vaccine Efficacy

Datasets

Release 1.2